Author:
Reddy Joseph A.,Leamon Christopher P.
Reference37 articles.
1. Covello K, Flefleh C, McGlinchey K et al (2008) Preclinical pharmacology of epothilone-folate conjugate BMS-753493, a tumor-targeting agent selected for clinical development. Paper presented at the Annual meeting of the American Association for Cancer Research, San Diego, CA
2. Harrison M, Swanton C (2008) Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. Expert Opin Investig Drugs 17:523–546
3. Hartmann LC, Keeney GL, Lingle WL et al (2007) Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer 121:938–942
4. Kaur G, Hollingshead M, Holbeck S et al (2006) Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product. Biochem J 396:235–242
5. Ladino CA, Chari RV, Bourret LA et al (1997) Folate-maytansinoids: target-selective drugs of low molecular weight. Int J Cancer 73:859–864
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献